Skip to main content
OpenTrials

Clinical trial condition

SARS-CoV-2

Explore clinical trials studying SARS-CoV-2. Study availability and eligibility vary by location and protocol.

173 public trials 4 recruiting studies
Refine in advanced search Browse all conditions

SARS-CoV-2 trial results

Completed

A Study to Evaluate Safety, Reactogenicity, and Immunogenicity of mRNA-1283 and mRNA-1273 Vaccines in Healthy Adults Between 18 Years and 55 Years of Age to Prevent COVID-19

NCT04813796

Conditions
COVID-19, Coronaviridae Infections, Coronavirus Infections, +10 more
Locations
  • Synexus Clinical Research US Phoenix Southeast, Inc. Chandler, Arizona, United States
  • Optimal Research San Diego, LLC San Diego, California, United States
  • Optimal Research Melbourne, LLC Melbourne, Florida, United States
  • Optimal Research Illinois, LLC Peoria, Illinois, United States
View Trial Details
Completed

Safety and Immune Response of Adjuvanted SARS-CoV-2 (COVID-19) Beta Variant RBD Recombinant Protein (DoCo-Pro-RBD-1 + MF59®) and mRNA (MIPSCo-mRNA-RBD-1) Vaccines in Healthy Adults

NCT05272605

Conditions
COVID-19, Coronaviridae Infections, Coronavirus Infections, +10 more
Locations
  • Vaccine and Immunisation Research Group, Doherty Institute, University of Melbourne Melbourne, Victoria, Australia
  • Royal Melbourne Hospital, Victorian Infectious Diseases Service (VIDS) Melbourne, Victoria, Australia
View Trial Details
Completed

FREEDOM COVID-19 Anticoagulation Strategy

NCT04512079

Conditions
COVID-19, Coronaviridae Infections, Coronavirus Infections, +15 more
Locations
  • Icahn School of Medicine at Mount Sinai New York, United States
  • Instituto do Coração - INCOR São Paulo, Brazil
  • Instituto Prevent Senior - IPS São Paulo, Brazil
  • Clínica de la Costa Barranquilla, Colombia
View all 21 locations
View Trial Details

Related conditions